Led high-performing team responsible for:• Strategy & target product profile (TPP) development for preclinical and early clinical assets• Competitive intelligence (CI) - covering indications and platform competition• Epidemiology, forecasting and valuations (at asset and corporate level)• Portfolio review and prioritisation • Opportunity assessments (integrated market, competitor, commercial and clinical analysis) • Deals analysis & benchmarking

Designed and led projects that provided in-depth, evidence-based analysis to guide strategy development. Clients were based across the US and Europe, ranging from top 10 pharma to biotech start-up and VC. Projects were commissioned from within R&D, commercial or corporate functions. Methodology was based on detailed desk research and KOL interviews.Key areas of expertise: • market analysis (segmentation, unmet needs, competitor landscape, pricing & reimb, market size)• commercial assessments of R&D products (developing / testing TPPs and positioning strategies)• forecasting and valuations • identifying and evaluating licensing opportunities, potential partners and M&A targets• portfolio planning • competitive intelligenceBuilt expert knowledge across a wide range of therapy areas.